KRYS — Krystal Biotech, Inc.

KRYSKrystal Biotech, Inc.

NAS · US · Healthcare · Biotechnology · krystalbio.com

303.07USD+1.21%Mkt Cap: 8.94B USDP/E: 40.48Last update: 2026-05-26

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company c…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap8.94B USD

Enterprise Value8.15B USD

Revenue (TTM)417.30M USD

Gross Profit366.08M USD

Net Income (TTM)204.83M USD

Revenue/Share14.36 USD

Last Price303.07 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees295

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS5011471027

Valuation

P/E (Trailing)40.48

P/E (Forward)30.18

PEG—

EV/EBITDA45.18

EV/Revenue19.54

P/S21.49

P/B7.01

EPS (TTM)7.46

EPS (Forward)10.08

52W Range

122.8092% of range319.48

52W High319.48 USD

52W Low122.80 USD

Profitability

Gross Margin94.08%

Oper. Margin46.14%

EBITDA Margin43.25%

Profit Margin52.64%

ROE16.80%

ROA15.36%

Growth

Revenue Growth31.90%

Earnings Growth52.50%

Cash Flow & Leverage

Operating CF200.87M USD

CapEx (TTM)11.95M USD

FCF Margin32.95%

FCF Yield1.54%

Net Debt-814.29M USD

Net Debt/EBITDA-4.51

Balance Sheet

Debt/Equity0.01

Current Ratio9.46

Quick Ratio8.82

Book Value/Sh43.37 USD

Cash/Share27.93 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.2 (Strong Buy)

Target (Mean)322.78 USD

Target Range241.00 USD – 399.00 USD

# Analysts9

Ownership

Shares Out.29.48M

Float23.37M

Insiders11.14%

Institutions99.24%

Short Interest

Short Ratio12.2d

Short % Float17.24%

Short % Out.10.50%

Shares Short3.10M

Short (prev mo.)3.14M

Technical

SMA 50271.99 (+11.4%)

SMA 200228.35 (+32.7%)

Beta0.49

S&P 52W Chg28.31%

Avg Vol (30d)289.69K

Avg Vol (10d)307.20K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—